Terminal Complement Inhibitor Eculizumab in Adult Patients with Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial

Fadi Fakhouri, Maryvonne Hourmant, Josep M. Campistol, Spero R. Cataland, Mario Espinosa, A. Osama Gaber, Jan Menne, Enrico E. Minetti, François Provôt, Eric Rondeau, Piero Ruggenenti, Laurent E. Weekers, Masayo Ogawa, Camille L. Bedrosian, Christophe M. Legendre

Research output: Contribution to journalArticlepeer-review

227 Scopus citations

Fingerprint

Dive into the research topics of 'Terminal Complement Inhibitor Eculizumab in Adult Patients with Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences